UAMS - Translational Research Institute

Eligibility

Eligible Ages

All ages

Eligible Sex

All

Accepts Healthy Volunteers

No

Criteria

Eligibility to participate in the Research Sample Repository Protocol:

Hematopoietic Cell (HC) or Other Cellular Therapy Donors

- Donors are eligible to participate in the Research Sample Repository if they have
donated or are scheduled to donate HCs or cellular therapy products to an allogeneic
recipient either by a marrow harvest or by apheresis. This includes adults with and
without decision making capacity and children.

- All donors registered on the National Marrow Donor Program (NMDP) Registry,
regardless of whether they have been requested to donate a product for a patient,
are eligible to participate in the Research Sample Repository.

Cord Blood Units (CBUs)

- Testable material from CBUs (Specimens) infused at treatment centers covered under
the C. W. Bill Young Transplantation Program are eligible for inclusion in the
Research Sample Repository. Material may be submitted by participating treatment
centers, centralized laboratories and Cord Blood Banks.

Hematopoietic Cell Transplantation or Other Cellular Therapy Recipients

- All U.S. recipients of allogeneic or autologous HC transplants or cellular therapies
are eligible to participate in the Research Sample Repository. This includes adults
with and without decision making capacity and children.

Patients with Marrow Toxic Injury

- Any patient who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Treatment Network (RITN) is eligible to participate in
the Research Sample Repository. This includes adults with and without
decision-making capacity and children.

- Eligible patients may have received support care only, growth factor support,
hematopoietic stem cell transplant or other appropriate medical treatment for marrow
toxic injury